Street J M, Singh H, Poulos A
Department of Chemical Pathology, Adelaide Children's Hospital, South Australia.
Biochem J. 1990 Aug 1;269(3):671-7. doi: 10.1042/bj2690671.
The metabolism of [1-14C]lignoceric acid (C24:0) and [1-14C]tetracosatetraenoic acid (C24:4, n-6) was studied in normal skin fibroblast cultures and in cultures from patients with defects in peroxisomal beta-oxidation (but normal peroxisomal numbers). Cells from X-linked adrenoleukodystrophy (ALD) patients with a presumed defect in a peroxisomal acyl-CoA synthetase, specific for fatty acids of carbon chain lengths greater than 22 (very-long-chain fatty acids; VLCFA), showed a relatively normal production of radiolabelled CO2 and water-soluble metabolites from [1-14C]C24:0. However, the products of synthesis from acetate de novo (released by beta-oxidation), i.e. C16 and C18 fatty acids, were decreased, and carbon chain elongation of the fatty acid was increased. In contrast, cell lines from two patients with an unidentified lesion in peroxisomal beta-oxidation (peroxisomal disease, PD) showed a marked deficiency in CO2 and water-soluble metabolite production, a decreased synthesis of C16 and C18 fatty acids and an increase in carbon chain elongation. The relatively normal beta-oxidation activity of ALD cells appears to be related to low uptake of substrate, as a defect in beta-oxidation is apparent when measurements are performed on cell suspensions under high uptake conditions. Oxidation of [1-14C]C24:4 was relatively normal in ALD cells and in the cells from one PD patient but abnormal in those from the other. Our data suggest that, despite the deficiency in VLCFA CoA synthetase, ALD cells retain a near normal ability to oxidize both saturated and polyunsaturated VLCFA under some culture conditions. However, acetate released by beta-oxidation of the saturated VLCFA and, to a much lesser degree, the polyunsaturated VLCFA, appears to be used preferentially for the production of CO2 and water-soluble products, and acetate availability for fatty acid synthesis in other subcellular compartments is markedly decreased. It is likely that the increased carbon chain elongation of the saturated VLCFA which is also observed reflects the increased availability of substrate (C24:0) and/or an increase in microsomal elongation activity in ALD cells.
在正常皮肤成纤维细胞培养物以及过氧化物酶体β氧化存在缺陷(但过氧化物酶体数量正常)的患者培养物中,研究了[1-14C]木蜡酸(C24:0)和[1-14C]二十四碳四烯酸(C24:4,n-6)的代谢情况。患有X连锁肾上腺脑白质营养不良(ALD)的患者,其过氧化物酶体酰基辅酶A合成酶可能存在缺陷,该酶对碳链长度大于22的脂肪酸(极长链脂肪酸;VLCFA)具有特异性,这些患者的细胞从[1-14C]C24:0产生放射性标记的二氧化碳和水溶性代谢物的能力相对正常。然而,由从头合成的乙酸盐(通过β氧化释放)生成的产物,即C16和C18脂肪酸减少,并且脂肪酸的碳链延长增加。相比之下,来自两名过氧化物酶体β氧化存在不明损伤的患者(过氧化物酶体疾病,PD)的细胞系,在二氧化碳和水溶性代谢物生成方面存在明显缺陷,C16和C18脂肪酸的合成减少,碳链延长增加。ALD细胞相对正常的β氧化活性似乎与底物摄取量低有关,因为在高摄取条件下对细胞悬液进行测量时,β氧化缺陷很明显。[1-14C]C24:4在ALD细胞和一名PD患者的细胞中的氧化相对正常,但在另一名PD患者的细胞中则异常。我们的数据表明,尽管VLCFA辅酶A合成酶存在缺陷,但在某些培养条件下,ALD细胞氧化饱和和多不饱和VLCFA的能力仍接近正常。然而,饱和VLCFA经β氧化释放的乙酸盐,以及程度小得多的多不饱和VLCFA经β氧化释放的乙酸盐,似乎优先用于生成二氧化碳和水溶性产物,并且其他亚细胞区室中用于脂肪酸合成的乙酸盐可用性显著降低。同样观察到的饱和VLCFA碳链延长增加,可能反映了底物(C24:0)可用性增加和/或ALD细胞中微粒体延长活性增加。